202 related articles for article (PubMed ID: 35276323)
21. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
[TBL] [Abstract][Full Text] [Related]
23. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis.
Gao D; Lu LP; Zhao ZG
Int Urol Nephrol; 2023 Oct; 55(10):2517-2526. PubMed ID: 36961513
[TBL] [Abstract][Full Text] [Related]
25. Unmet challenges in membranous nephropathy.
Salant DJ
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
[TBL] [Abstract][Full Text] [Related]
26. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G
Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733
[TBL] [Abstract][Full Text] [Related]
27. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.
Safar-Boueri L; Piya A; Beck LH; Ayalon R
Pediatr Nephrol; 2021 Jan; 36(1):19-30. PubMed ID: 31811540
[TBL] [Abstract][Full Text] [Related]
28. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
[TBL] [Abstract][Full Text] [Related]
29. Advances of the experimental models of idiopathic membranous nephropathy (Review).
Jiang HX; Feng Z; Zhu ZB; Xia CH; Zhang W; Guo J; Liu BL; Wang Y; Liu YN; Liu WJ
Mol Med Rep; 2020 May; 21(5):1993-2005. PubMed ID: 32186751
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of Primary Membranous Nephropathy.
Gu Y; Xu H; Tang D
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808418
[TBL] [Abstract][Full Text] [Related]
31. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
32. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
33. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
[TBL] [Abstract][Full Text] [Related]
34. M-type phospholipase A
Kanda S; Horita S; Yanagihara T; Shimizu A; Hattori M
Pediatr Nephrol; 2017 Apr; 32(4):713-717. PubMed ID: 27921164
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
36. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
[TBL] [Abstract][Full Text] [Related]
37. Membranous nephropathy: A ten-year journey of discoveries.
Cai Q; Hendricks AR
Semin Diagn Pathol; 2020 May; 37(3):116-120. PubMed ID: 32061439
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy.
Watanabe S; Suzuki T; Han W; Nakata M; Koitabashi K; Ichikawa D; Kamijo-Ikemori A; Koike J; Shibagaki Y
Intern Med; 2021 Oct; 60(19):3125-3128. PubMed ID: 33840692
[TBL] [Abstract][Full Text] [Related]
39. Membranous nephropathy.
Dantas M; Silva LBB; Pontes BTM; Dos Reis MA; de Lima PSN; Moysés Neto M
J Bras Nefrol; 2023; 45(2):229-243. PubMed ID: 37527529
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
